Risks of in utero exposure to valproate

JAMA

Volumn 309, Issue 16, 2013, Pages 1730-1731

  Meador, Kimford J ^a   Loring, David W ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

AUTISM; BIPOLAR DISORDER; CLEFT PALATE; CRANIOFACIAL SYNOSTOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG USE; EDITORIAL; EPILEPSY; FETUS RISK; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPOSPADIAS; INTELLIGENCE QUOTIENT; MATERNAL CARE; MEDICAL INFORMATION; MENTAL DISEASE; OUTCOME ASSESSMENT; PAIN; PATIENT COUNSELING; POLYDACTYLY; PREGNANCY; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SEIZURE; SPINAL DYSRAPHISM;

EID: 84876579424     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.4001     Document Type: Editorial

References (15)

1. Adedinsewo DA. Trends in Valproate Prescriptions for Non-Epilepsy Indications among Women Aged 15-44 Years U.S. 1996-2007 [A Population-Based Study] [master's thesis]. Atlanta, GA; Emory University; 2012. https://etd.library.emory.edu/view/record/pid/emory:bqmst. Accessed March 15, 2013.
2. Harden CL, Meador KJ, Pennell PB, et al American Academy of Neurology; American Epilepsy Society. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009;73(2):133-141.
3. Meador KJ, Baker GA, Browning N, et al NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009;360(16):1597-1605.
4. US Food and Drug Administration (FDA). FDA Drug Safety Communication: Children Born to Mothers Who Took Valproate Products While Pregnant May Have Impaired Cognitive Development. FDA website. http://www.fda.gov/Drugs/ DrugSafety/ucm261543.htm. June 30, 2011. Accessed March 15, 2013.
5. Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000;37(7):489-497. (Pubitemid 30428234)
6. Rasalam AD, Hailey H, Williams JH, et al. Characteristics of fetal anticonvulsant syndrome-associated autistic disorder. Dev Med Child Neurol. 2005;47(8):551-555. (Pubitemid 41131614)
7. Bromley RL, Mawer G, Clayton-Smith J, Baker GA; Liverpool and Manchester Neurodevelopment Group. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology. 2008;71(23):1923-1924.
8. Bromley RL, Mawer GE, Briggs M, et al Liverpool and Manchester Neurodevelopment Group. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs [published online January 31, 2013]. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2012-304270.
9. Christensen J, Grønborg TK, Sørensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA . 2013;309(16):1696-1703.
10. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res. 2008;81(1):1-13.
11. Meador KJ, Baker GA, Browning N, et al NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study [published online January 23, 2013]. Lancet Neurol. 2013;12(3):244-252. doi:10.1016/S1474-4422(12)70323-X.
12. Centers for Disease Control and Prevention (CDC). Valproate: a new cause of birth defects-report from Italy and follow-up from France. MMWRMorb Mortal Wkly Rep. 1983;32(33):438-439.
13. Jentink J, Loane MA, Dolk H, et al EUROCAT Antiepileptic Study Working Group. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med. 2010;362(23):2185-2193.
14. Wisner KL, Leckman-Westin E, Finnerty M, Essock SM. Valproate prescription prevalence among women of childbearing age. Psychiatr Serv. 2011;62(2):218-220.
15. Gilboa SM, Broussard CS, Devine OJ, et al. Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States. Am J Med Genet C Semin Med Genet. 2011;157(3):234-246.